Illumina, Inc. - Wutah dodolan triwulanan ILMN

Logo korporat perusahaan Illumina Inc (ILMN)

Illumina, Inc. (ILMN) maintains revenue stability through the consistent sale of consumables, as evidenced by the quarterly revenue trend where the parameter settled at 4.30. The reliance of researchers on grants provides crisis resilience, while scheduled plant capacity during the modernization of lines for new genomic platforms offers additional support.

ILMN Wutah dodolan triwulanan Illumina Inc (04.07.2022 - 20.11.2026)

Rincian metrik keuangan lan pasar Illumina (ILMN)

- kuotasi saiki lan rata-rata prakiraan nilai:
- indikator dhuwit lan ilining kas:
Analisis kabeh metrik perusahaan:Illumina, Inc. - ILMN
Produk seri illumina.com

Comparative asset analysis requires a precise determination of when fundamental momentum fades. This metric calculates the percentage change in revenue from the current quarter to the previous one, converting discrete data into daily price action to identify business deceleration. For Illumina, Inc. (ILMN), this is critical: equipment dumping stimulates reagent sales, creating long-term customer dependency. By analyzing quarterly revenue growth rates, an investor can detect stagnation in expansion in a timely manner and avoid purchasing an overvalued asset.

Perusahaan pesaing

A - Wutah pendapatan kuartal marang kuartal|Tingkat wutah dodolan sajrone kuartal Quest Diagnostics Incorporated DGX|EXAS: Wutah pendapatan triwulanan|RVTY (Revvity) - Wutah pendapatan kuartal marang kuartal|BIO (Bio-Rad Laboratories, Inc.) - Wutah pendapatan triwulanan|Tingkat wutah pendapatan sajrone kuartal Anbio Biotechnology NNNN|Wutah dodolan triwulanan SHC (Sotera Health Company)|Wutah pendapatan kuartal marang kuartal QDEL (quidel.com)|Wutah pendapatan triwulanan OPK (opko.com)|Tambahing pendapatan triwulanan CDNA|MRVI: Wutah dodolan triwulanan|Tambahing pendapatan triwulanan FLGT (Fulgent Corp)|LAB: Wutah pendapatan triwulanan|Tingkat wutah pendapatan sajrone kuartal cytekbio.com (CTKB)|OSUR (OraSure Corp) - Wutah pendapatan triwulanan|Exagen (XGN) - Tingkat wutah dodolan sajrone kuartal|Wutah pendapatan kuartal marang kuartal MDxHealth, Inc. (MDXH)|Lucid Diagnostics, Inc - Wutah dodolan kuartal marang kuartal|Wutah pendapatan kuartal marang kuartal Prenetics PRE|Insight Molecular (IMDX) - Tingkat wutah pendapatan sajrone kuartal|Trinity Biotech Corp - Wutah pendapatan triwulanan|Tingkat wutah dodolan sajrone kuartal ProPhase PRPH|AIMD: Wutah pendapatan triwulanan|CODX - Tingkat wutah dodolan sajrone kuartal|Wutah pendapatan kuartal marang kuartal Heart Test Laboratories, Inc.|Wutah pendapatan kuartal marang kuartal BMRA|Wutah pendapatan triwulanan CDIO|Onconetix - Wutah dodolan kuartal marang kuartal|Wutah pendapatan kuartal marang kuartal viraxbiolabs.com VRAX|Tingkat wutah dodolan sajrone kuartal Bluejay (BJDX)|AWH: Wutah dodolan triwulanan|Tingkat wutah dodolan sajrone kuartal Accelerate Diagnostics, Inc. AXDX|Centogene (CNTG) - Wutah pendapatan kuartal marang kuartal|Dinamika pendapatan kuartal marang kuartal ENZ (Enzo)|Wutah dodolan kuartal marang kuartal Fresh2 (FRES)|Genetic Technologies (GENE) - Tingkat wutah dodolan sajrone kuartal|Wutah pendapatan triwulanan ME|Wutah pendapatan kuartal marang kuartal PMD (Psychemedics Corporation)